Quite a lot actually…In a New Statesman article, sponsored by Merck, George Freeman (my local MP) was asked for his thoughts on future of Personalised Medicine by Merck’s Head of Public Affairs, Larushka Mellor.George described himself as one of the “early evangelists for the new […]
I recently presented at the Festival of Genomics on a proof-of-concept experiment we ran in my lab to generate single-cell copy number profiles. The experimental work was done in 2014 and we’re now looking to port the method over to Fluidigm’s C1 chips, possibly using […]
The HiSeq 4000 was Illumina’s way of making the patterned flowcell technology available to non X Ten customers, and opening up patterned flowcells to applications other than Human genomes. The list of supported library preps is still relatively small: TruSeq Nano, TruSeq PCR Free, Nextera […]
Illumina are offering the chance to win a Mini in a competition to drive interest in their MiniSeq, the competition grand prize winner gets a MiniSeq and an Illumina-branded Mini Cooper (probably pumpkin, possibly black-and-white).The competition is a grant program; to enter tell Illumina in […]
President Obama’s “moon shot” to get a cure for cancer has received a lot of coverage, both positive and negative. GenomeWeb pulled together some of this in a Scan article earlier this week: “Is a Cure Even Possible?”. This reported on coverage from The New […]
Scientists from David Zhang’s group in the NABlab at Rice University, Texas, and nanoString technologies had their work featured on the front cover of Decembers Nature Methods: Continuously tunable nucleic acid hybridization probes. The paper describes their work with X-probes and/or ToeHold probes to tune […]
Fluidigm President and CEO Gajus Worthington sent a message to C1 users today that reported problems with their C1 IFCs, particularly those for medium-size cells (10–17µm), The issue is an unacceptably high level of doublets i.e. two-cells in a capture site rather than one. The […]
Jay was busy at JP Morgan. GenomeWeb have excellent coverage of all the big announcements; for me the most interesting is the information about Grail – the new liquid biopsy screening company and I covered that earlier today. In this post I thought I’d give […]
Illumina’s been busy in the cell-free DNA world, on the eve of JP Morgan Jay Flatley announced a new company, Grail, to screen cell free DNA for cancer. And at the end of last week Illumina ramped up litigation against companies using cfDNA for NIPT […]
Christmas came a little early to my lab with the delivery of two new HiSeq 4000 instruments. It would have been nice if these had come gift wrapped as it is the Christmas season, but alas no. Perhaps next year Illumina can get a little […]
